TerraPower reaches market-scale production of Ac-225

October 4, 2024, 9:30AMNuclear News

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the pharmaceutical industry through weekly production runs. As a result, TerraPower Isotopes said its actinium, after further manufacturing, is now used in multiple drug developers’ radiopharmaceuticals in human clinical trials across the globe.

To continue reading, log in or create a free account!

Related Articles

Reflections on NOW

September 8, 2025, 9:29AMNuclear News

Last month, I talked about my goal of strengthening ANS’s voice, in part by attending three conferences. I have now checked the first event off that list: the Nuclear Opportunities...